EchoIQ’s heart-failure AI just hit Mayo’s testing track, chasing FDA clearance and a shot at fixing America’s $60bn hospital headache.

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

As a physician-centric, AI-powered organization, Astrana sees the acquisition as a way to scale its proactive, high-quality care model using proprietary tech and data infrastructure. The company ...

AI’s diagnostic makeover is unfolding across every layer of medicine. Discover how it's helping doctors today!

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- USA News Group News Commentary - This week in Geneva, the World Health ...

Designed to support clinicians with same-day assessments, the platform aims to improve outcomes while reducing reliance on ...

Absci (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the appointment of veteran biopharmaceutical executive ...

The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms.

Schrödinger, Inc. (NASDAQ:SDGR) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Schrödinger, Inc. ...

As the head of HHS, Kennedy said his federal department is undergoing an “AI revolution.” He implored viewers to “stop ...